Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver ...

In response to the growing need for addiction recovery services, Renaissance Recovery is expanding its Florida facility with ...

Webinar to be held on Wednesday, September 3, 2025 at 4:30 p.m. ET ...

MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q2) and six months (H1) ended June 30, ...

Utah Governor Spencer Cox opens 190,000-square-foot building; Nusano platform capable of producing more than 40 different radioisotopes for healthcare and industry; New supplies o ...

MONTRÉAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “ Company ”), a leading Canadian Healthtech company, announces it has filed its unaudited Quarterly ...

Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 in New York, NY on ...

VALENCIA, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced ...

About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring ...

The Cantor Global Healthcare Conference, being held in New York, including a fireside chat with Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer and Matt Hopper, SVP of ...

As of June 30, 2025, the Company had $49.9 million, net of outstanding indebtedness with a weighted-average annual interest rate of 5.0% and a weighted-average maturity of approximately 16 years. For ...

Applied StemCell, a genome engineering product and services company, announced today the appointment of Dolores Baksh, Ph.D., as Chief Executive Officer. Company founder and former CEO Ruby Tsai, Ph.D ...